SCHEMBL16760583

SCHEMBL16760583

COc1cc(-c2oc3cc(OC)c(OC)c(O)c3c(=O)c2O)ccc1O

nearest known ligand 0.82

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK2 Q9HBH9 1/20 0.82
MEN1 O00255 2/20 0.72
KMT2A Q03164 2/20 0.72
CA12 O43570 1/20 0.72
CA2 P00918 1/20 0.72
CYP1A1 P04798 1/20 0.72
CYP1A2 P05177 1/20 0.72
CA4 P22748 1/20 0.72
PPARG P37231 1/20 0.72
CA7 P43166 1/20 0.72
XDH P47989 1/20 0.72
CYP1B1 Q16678 1/20 0.72
IPMK Q8NFU5 1/20 0.72
IP6K2 Q9UHH9 1/20 0.72
ALOX5 P09917 4/20 0.71
ABCB1 P08183 2/20 0.67
ABCG2 Q9UNQ0 2/20 0.67
TUBB4A P04350 3/20 0.64
TUBB P07437 3/20 0.64
TUBA3C P0DPH7 3/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chrysosplenol B SCHEMBL2369883 0.93 ABCG2 (0.78) MKNK2MEN1KMT2AXDHALOX5
SCHEMBL31058466 0.93 MKNK2 (0.86) MKNK2XDHALOX5ABCB1ABCG2
Chrysosplenol B SCHEMBL29558792 0.93 ABCG2 (0.78) MKNK2MEN1KMT2AXDHALOX5
SCHEMBL29143220 0.93 MKNK2 (0.86) MKNK2XDHALOX5ABCB1ABCG2
SCHEMBL19461012 0.93 TUBB4A (0.74) MKNK2MEN1KMT2ACA12CA2
SCHEMBL29647956 0.93 TUBB4A (0.74) MKNK2MEN1KMT2ACA12CA2
SCHEMBL38660678 0.91 MKNK2 (0.84) MKNK2MEN1KMT2ACA12CA2
SCHEMBL10432667 0.90 MKNK2 (1.00) MKNK2MEN1KMT2ACYP1A1CYP1A2
SCHEMBL24514616 0.90 XDH (0.68) MKNK2MEN1KMT2ACA12CA2
SCHEMBL1144456 0.88 ABCB1 (0.86) MKNK2MEN1KMT2ACA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240033246-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (IL) 2024-02-01 US claimed
EP-4259173-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) 2023-10-18 EP claimed
US-11752125-B2 Anti-neuroinflammatory and protective compounds in Achillea fragrantissima THE STATE OF ISRAEL MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (IL) 2023-09-12 US claimed
WO-2022123573-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) 2022-06-16 WO claimed
EP-3074029-B1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT AGRICULTURAL RES ORGANIZATION ARO VO (IL) 2020-07-29 EP claimed
US-20170020842-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) 2017-01-26 US claimed
US-20250073292-A1 PELARGONIUM GRAVEOLENS EXTRACT FOR THE TREATMENT OF TRAUMATIC BRAIN INJURIES THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL R (IL) 2025-03-06 US disclosed
WO-2024154119-A1 ENRICHED PELARGONIUM GRAVEOLENS EXTRACTS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURIES THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) 2024-07-25 WO disclosed
EP-4380587-A1 PELARGONIUM GRAVEOLENS EXTRACT FOR THE TREATMENT OF TRAUMATIC BRAIN INJURIES The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) 2024-06-12 EP disclosed
CN-118176008-A Pelargonium graveolens extract for treating traumatic brain injury 以色列国家农业与农村发展部农业研究组织(ARO)(Volciti 中心) 2024-06-11 CN disclosed
US-20240033246-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (IL) 2024-02-01 US disclosed
US-20240033246-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. (IL) 2024-02-01 US disclosed
CN-117279653-A Compounds for the treatment of ocular diseases and disorders 以色列国家农业和农村发展农业研究组织沃尔坎尼中心 2023-12-22 CN disclosed
US-20170020842-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) 2017-01-26 US disclosed
US-20170020842-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER) (IL) 2017-01-26 US disclosed
CN-106102757-A Neuritis and protectiveness compound in the Achillea ageratum of pole 以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心 2016-11-09 CN disclosed
EP-3074029-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) 2016-10-05 EP disclosed
EP-3074029-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) (IL) 2016-10-05 EP disclosed
WO-2015079390-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT,AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER). (IL) 2015-06-04 WO disclosed
WO-2015079390-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT,AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI CENTER). (IL) 2015-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240033246-A1 COMPOUNDS FOR TREATING EYE DISEASES AND DISORDERS TEAD3, TEAD4, TEAD1 MKNK2 1064/4885MEN1 2709/4885KMT2A 4211/4885
US-20170020842-A1 ANTI-NEUROINFLAMMATORY AND PROTECTIVE COMPOUNDS IN ACHILLEA FRAGRANTISSIMA TARDBP, GSTK1, HTT MKNK2 2372/4885MEN1 3264/4885KMT2A 1189/4885
US-11752125-B2 Anti-neuroinflammatory and protective compounds in Achillea fragrantissima TARDBP, GSTK1, HTT MKNK2 2372/4885MEN1 3264/4885KMT2A 1189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.